Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
147M
-
Number of holders
-
991
-
Total 13F shares, excl. options
-
187M
-
Shares change
-
+1.07M
-
Total reported value, excl. options
-
$50.8B
-
Value change
-
+$289M
-
Put/Call ratio
-
1.14
-
Number of buys
-
413
-
Number of sells
-
-483
-
Price
-
$271.36
Significant Holders of BIOGEN INC. - COM (BIIB) as of Q2 2017
1,147 filings reported holding BIIB - BIOGEN INC. - COM as of Q2 2017.
BIOGEN INC. - COM (BIIB) has 991 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 187M shares
.
Largest 10 shareholders include BlackRock Inc. (18.1M shares), PRIMECAP MANAGEMENT CO/CA/ (15.4M shares), VANGUARD GROUP INC (14.5M shares), STATE STREET CORP (9.72M shares), Clearbridge Investments, LLC (9.29M shares), PRICE T ROWE ASSOCIATES INC /MD/ (8.95M shares), FMR LLC (6.1M shares), WELLINGTON MANAGEMENT GROUP LLP (5.23M shares), Invesco Ltd. (3.44M shares), and NORTHERN TRUST CORP (3.02M shares).
This table shows the top 991 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.